Menu Search
Equities

Otsuka Holdings Co Ltd

4578:TYO

Otsuka Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)8,910.00
  • Today's Change-42.00 / -0.47%
  • Shares traded1.05m
  • 1 Year change+59.71%
  • Beta0.9951
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income142,655172,954163,638
Depreciation/depletion97,77793,76184,855
Non-Cash items149,01113,111(11170)
Cash taxes paid, supplemental80,98235,25052,144
Cash interest paid, supplemental3,2123,4602,662
Changes in working capital(106211)(67978)(8459)
Total cash from operations283,232211,848228,864
INVESTING
Capital expenditures(114673)(107787)(113152)
Other investing and cash flow items, total(75865)26,21217,864
Total cash from investing(190538)(81575)(95288)
FINANCING
Financing cash flow items(92)(22)(46)
Total cash dividends paid(55653)(55561)(55984)
Issuance (retirement) of stock, net(1)0(1)
Issuance (retirement) of debt, net(4514)(39891)(39813)
Total cash from financing(60260)(95474)(95844)
NET CHANGE IN CASH
Foreign exchange effects9,27426,15116,101
Net change in cash41,70860,95053,833
Net cash-begin balance/reserved for future use471,634410,684356,851
Net cash-end balance/reserved for future use513,341471,634410,684
SUPPLEMENTAL INCOME
Depreciation, supplemental97,77793,76184,855
Cash interest paid, supplemental3,2123,4602,662
Cash taxes paid, supplemental80,98235,25052,144
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.